Olga, WA, United States of America

John C Babcock


Average Co-Inventor Count = 6.0

ph-index = 6

Forward Citations = 142(Granted Patents)


Company Filing History:


Years Active: 1992-1996

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of John C. Babcock

Introduction

John C. Babcock is a notable inventor based in Olga, Washington. He has made significant contributions to the field of pharmaceutical formulations, particularly in the stabilization of aminosteroids. With a total of six patents to his name, Babcock's work has had a considerable impact on the development of effective therapeutic agents.

Latest Patents

Babcock's latest patents focus on the stabilization of amino-substituted steroid therapeutic agents for topical ophthalmic and other pharmaceutical formulations. His inventions provide methods for stabilizing these agents using effective amounts of lightly cross-linked carboxy-containing polymers. Additionally, he has developed methods for stabilizing and solubilizing these therapeutic agents with selected cyclodextrin derivatives. These derivatives include hydroxypropyl, hydroxyethyl, glucosyl, maltosyl, and maltotriosyl derivatives of β- and γ-cyclodextrin. His patents also describe stabilized and stabilized/solubilized pharmaceutical compositions that are adapted for various routes of administration.

Career Highlights

Babcock is associated with Insite Vision Corporation, where he has been instrumental in advancing pharmaceutical technologies. His innovative approaches have led to the development of new formulations that enhance the efficacy of therapeutic agents.

Collaborations

Some of his notable coworkers include Lyle M. Bowman and Santosh K. Chandrasekaran. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

John C. Babcock's contributions to the field of pharmaceutical formulations through his innovative patents demonstrate his commitment to improving therapeutic agents. His work continues to influence the development of effective treatments in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…